nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—NEU2—Sialic acid metabolism—ST6GAL1—type 2 diabetes mellitus	0.0212	0.0979	CbGpPWpGaD
Zanamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—ST6GAL1—type 2 diabetes mellitus	0.0147	0.0681	CbGpPWpGaD
Zanamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—ST6GAL1—type 2 diabetes mellitus	0.012	0.0556	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—ST6GAL1—type 2 diabetes mellitus	0.00765	0.0353	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—ADAMTS9—type 2 diabetes mellitus	0.00539	0.0249	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PCSK2—type 2 diabetes mellitus	0.00445	0.0206	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—WFS1—type 2 diabetes mellitus	0.00397	0.0183	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—ST6GAL1—type 2 diabetes mellitus	0.00395	0.0183	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.00367	0.017	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.00348	0.0161	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.00271	0.0125	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.00264	0.0122	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—F7—type 2 diabetes mellitus	0.00263	0.0122	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	0.00256	0.0118	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.00252	0.0116	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.00252	0.0116	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.00252	0.0116	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.00228	0.0105	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.00224	0.0104	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	0.00208	0.00963	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—DPP4—type 2 diabetes mellitus	0.00208	0.00963	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GIP—type 2 diabetes mellitus	0.00201	0.00927	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	0.00194	0.00896	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.00191	0.00881	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	0.00191	0.00881	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	0.00188	0.00867	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—BHMT—type 2 diabetes mellitus	0.00187	0.00865	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGDS—type 2 diabetes mellitus	0.00163	0.00756	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AANAT—type 2 diabetes mellitus	0.00163	0.00756	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.00155	0.00719	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CDO1—type 2 diabetes mellitus	0.00155	0.00716	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GPD2—type 2 diabetes mellitus	0.00155	0.00716	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.00151	0.007	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.00151	0.00696	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AK1—type 2 diabetes mellitus	0.00148	0.00683	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.00146	0.00676	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.00139	0.00643	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC5A4—type 2 diabetes mellitus	0.00136	0.00631	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—MAT1A—type 2 diabetes mellitus	0.00136	0.00631	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.00136	0.00628	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.00133	0.00616	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.00132	0.00611	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—G6PC—type 2 diabetes mellitus	0.00132	0.00609	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ENPP1—type 2 diabetes mellitus	0.00132	0.00609	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.00132	0.00609	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ND1—type 2 diabetes mellitus	0.00132	0.00609	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HBA2—type 2 diabetes mellitus	0.00132	0.00609	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GCGR—type 2 diabetes mellitus	0.00128	0.0059	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—F7—type 2 diabetes mellitus	0.00125	0.00577	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.00123	0.00568	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.00122	0.00562	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYTB—type 2 diabetes mellitus	0.00121	0.00557	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—OXCT1—type 2 diabetes mellitus	0.00121	0.00557	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SRD5A1—type 2 diabetes mellitus	0.00117	0.00543	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—STAR—type 2 diabetes mellitus	0.00112	0.00518	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ACACA—type 2 diabetes mellitus	0.00112	0.00518	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HSD17B3—type 2 diabetes mellitus	0.00112	0.00518	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.00111	0.00514	CbGpPWpGaD
Zanamivir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.0011	0.0014	CcSEcCtD
Zanamivir—Convulsion—Orlistat—type 2 diabetes mellitus	0.00109	0.0014	CcSEcCtD
Zanamivir—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00109	0.00139	CcSEcCtD
Zanamivir—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00109	0.00139	CcSEcCtD
Zanamivir—Myalgia—Valsartan—type 2 diabetes mellitus	0.00109	0.00139	CcSEcCtD
Zanamivir—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00109	0.00139	CcSEcCtD
Zanamivir—Dizziness—Glipizide—type 2 diabetes mellitus	0.00109	0.00139	CcSEcCtD
Zanamivir—Anxiety—Valsartan—type 2 diabetes mellitus	0.00108	0.00138	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00108	0.00138	CcSEcCtD
Zanamivir—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00108	0.00138	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.00108	0.00498	CbGpPWpGaD
Zanamivir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00108	0.00137	CcSEcCtD
Zanamivir—Myalgia—Orlistat—type 2 diabetes mellitus	0.00107	0.00137	CcSEcCtD
Zanamivir—NEU2—Metabolism—CBS—type 2 diabetes mellitus	0.00107	0.00497	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCC8—type 2 diabetes mellitus	0.00107	0.00497	CbGpPWpGaD
Zanamivir—Anxiety—Orlistat—type 2 diabetes mellitus	0.00107	0.00137	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00107	0.00136	CcSEcCtD
Zanamivir—Sinusitis—Ramipril—type 2 diabetes mellitus	0.00106	0.00136	CcSEcCtD
Zanamivir—Discomfort—Orlistat—type 2 diabetes mellitus	0.00106	0.00136	CcSEcCtD
Zanamivir—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00106	0.00135	CcSEcCtD
Zanamivir—Malaise—Metformin—type 2 diabetes mellitus	0.00105	0.00134	CcSEcCtD
Zanamivir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00105	0.00134	CcSEcCtD
Zanamivir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00105	0.00133	CcSEcCtD
Zanamivir—Vomiting—Glipizide—type 2 diabetes mellitus	0.00104	0.00133	CcSEcCtD
Zanamivir—Syncope—Metformin—type 2 diabetes mellitus	0.00104	0.00133	CcSEcCtD
Zanamivir—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00104	0.00133	CcSEcCtD
Zanamivir—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00104	0.00133	CcSEcCtD
Zanamivir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00104	0.00133	CcSEcCtD
Zanamivir—Infection—Valsartan—type 2 diabetes mellitus	0.00104	0.00132	CcSEcCtD
Zanamivir—Rash—Glipizide—type 2 diabetes mellitus	0.00104	0.00132	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.00104	0.00479	CbGpPWpGaD
Zanamivir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00103	0.00132	CcSEcCtD
Zanamivir—NEU2—Metabolism—COX2—type 2 diabetes mellitus	0.00103	0.00478	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC5A2—type 2 diabetes mellitus	0.00103	0.00478	CbGpPWpGaD
Zanamivir—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00103	0.00132	CcSEcCtD
Zanamivir—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00103	0.00132	CcSEcCtD
Zanamivir—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00103	0.00131	CcSEcCtD
Zanamivir—Headache—Glipizide—type 2 diabetes mellitus	0.00103	0.00131	CcSEcCtD
Zanamivir—Shock—Valsartan—type 2 diabetes mellitus	0.00103	0.00131	CcSEcCtD
Zanamivir—Infection—Orlistat—type 2 diabetes mellitus	0.00102	0.00131	CcSEcCtD
Zanamivir—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00102	0.00131	CcSEcCtD
Zanamivir—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00102	0.0013	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.00102	0.00471	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NCOA6—type 2 diabetes mellitus	0.00102	0.0047	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.00102	0.00469	CbGpPWpGaD
Zanamivir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00101	0.00129	CcSEcCtD
Zanamivir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00101	0.00129	CcSEcCtD
Zanamivir—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00101	0.00129	CcSEcCtD
Zanamivir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00101	0.00129	CcSEcCtD
Zanamivir—Agitation—Irbesartan—type 2 diabetes mellitus	0.00101	0.00129	CcSEcCtD
Zanamivir—Urticaria—Glyburide—type 2 diabetes mellitus	0.001	0.00128	CcSEcCtD
Zanamivir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.001	0.00128	CcSEcCtD
Zanamivir—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000999	0.00128	CcSEcCtD
Zanamivir—NEU2—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000999	0.00462	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—UCP2—type 2 diabetes mellitus	0.000999	0.00462	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—UCP3—type 2 diabetes mellitus	0.000999	0.00462	CbGpPWpGaD
Zanamivir—Anorexia—Valsartan—type 2 diabetes mellitus	0.000994	0.00127	CcSEcCtD
Zanamivir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000992	0.00127	CcSEcCtD
Zanamivir—Myalgia—Metformin—type 2 diabetes mellitus	0.000991	0.00126	CcSEcCtD
Zanamivir—Malaise—Irbesartan—type 2 diabetes mellitus	0.00099	0.00126	CcSEcCtD
Zanamivir—Headache—Pioglitazone—type 2 diabetes mellitus	0.000986	0.00126	CcSEcCtD
Zanamivir—Syncope—Irbesartan—type 2 diabetes mellitus	0.000985	0.00126	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000984	0.00126	CcSEcCtD
Zanamivir—Discomfort—Metformin—type 2 diabetes mellitus	0.000979	0.00125	CcSEcCtD
Zanamivir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000979	0.00125	CcSEcCtD
Zanamivir—Nausea—Glipizide—type 2 diabetes mellitus	0.000976	0.00124	CcSEcCtD
Zanamivir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000975	0.00124	CcSEcCtD
Zanamivir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000971	0.00124	CcSEcCtD
Zanamivir—Pain—Gliclazide—type 2 diabetes mellitus	0.000971	0.00124	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000968	0.00447	CbGpPWpGaD
Zanamivir—Rash—Glimepiride—type 2 diabetes mellitus	0.000966	0.00123	CcSEcCtD
Zanamivir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000966	0.00123	CcSEcCtD
Zanamivir—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000965	0.00123	CcSEcCtD
Zanamivir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000963	0.00123	CcSEcCtD
Zanamivir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000962	0.00123	CcSEcCtD
Zanamivir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000962	0.00123	CcSEcCtD
Zanamivir—Headache—Glimepiride—type 2 diabetes mellitus	0.00096	0.00123	CcSEcCtD
Zanamivir—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000959	0.00122	CcSEcCtD
Zanamivir—Cough—Irbesartan—type 2 diabetes mellitus	0.000958	0.00122	CcSEcCtD
Zanamivir—Headache—Sitagliptin—type 2 diabetes mellitus	0.000957	0.00122	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00095	0.00121	CcSEcCtD
Zanamivir—Agitation—Losartan—type 2 diabetes mellitus	0.00095	0.00121	CcSEcCtD
Zanamivir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000946	0.00121	CcSEcCtD
Zanamivir—Infection—Metformin—type 2 diabetes mellitus	0.000943	0.0012	CcSEcCtD
Zanamivir—NEU2—Metabolism—PCK1—type 2 diabetes mellitus	0.000939	0.00434	CbGpPWpGaD
Zanamivir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000939	0.0012	CcSEcCtD
Zanamivir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000935	0.00119	CcSEcCtD
Zanamivir—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000935	0.00119	CcSEcCtD
Zanamivir—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000935	0.00119	CcSEcCtD
Zanamivir—Shock—Metformin—type 2 diabetes mellitus	0.000934	0.00119	CcSEcCtD
Zanamivir—Malaise—Losartan—type 2 diabetes mellitus	0.000932	0.00119	CcSEcCtD
Zanamivir—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000932	0.00119	CcSEcCtD
Zanamivir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000931	0.00119	CcSEcCtD
Zanamivir—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00093	0.00119	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000928	0.00118	CcSEcCtD
Zanamivir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000928	0.00118	CcSEcCtD
Zanamivir—Syncope—Losartan—type 2 diabetes mellitus	0.000927	0.00118	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000924	0.00427	CbGpPWpGaD
Zanamivir—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000924	0.00118	CcSEcCtD
Zanamivir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000922	0.00118	CcSEcCtD
Zanamivir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000914	0.00117	CcSEcCtD
Zanamivir—Nausea—Glimepiride—type 2 diabetes mellitus	0.00091	0.00116	CcSEcCtD
Zanamivir—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000909	0.00116	CcSEcCtD
Zanamivir—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000908	0.00116	CcSEcCtD
Zanamivir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000908	0.00116	CcSEcCtD
Zanamivir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000907	0.00116	CcSEcCtD
Zanamivir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000906	0.00116	CcSEcCtD
Zanamivir—Anorexia—Metformin—type 2 diabetes mellitus	0.000905	0.00116	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000902	0.00417	CbGpPWpGaD
Zanamivir—Cough—Losartan—type 2 diabetes mellitus	0.000902	0.00115	CcSEcCtD
Zanamivir—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000902	0.00115	CcSEcCtD
Zanamivir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000899	0.00115	CcSEcCtD
Zanamivir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000897	0.00114	CcSEcCtD
Zanamivir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000897	0.00114	CcSEcCtD
Zanamivir—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000896	0.00114	CcSEcCtD
Zanamivir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000896	0.00114	CcSEcCtD
Zanamivir—Infection—Irbesartan—type 2 diabetes mellitus	0.00089	0.00114	CcSEcCtD
Zanamivir—Fatigue—Orlistat—type 2 diabetes mellitus	0.000888	0.00113	CcSEcCtD
Zanamivir—Shock—Irbesartan—type 2 diabetes mellitus	0.000882	0.00113	CcSEcCtD
Zanamivir—Pain—Orlistat—type 2 diabetes mellitus	0.000881	0.00112	CcSEcCtD
Zanamivir—Arthralgia—Losartan—type 2 diabetes mellitus	0.00088	0.00112	CcSEcCtD
Zanamivir—Myalgia—Losartan—type 2 diabetes mellitus	0.00088	0.00112	CcSEcCtD
Zanamivir—NEU2—Metabolism—HK1—type 2 diabetes mellitus	0.000879	0.00406	CbGpPWpGaD
Zanamivir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000879	0.00112	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000878	0.00406	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000877	0.00406	CbGpPWpGaD
Zanamivir—Anxiety—Losartan—type 2 diabetes mellitus	0.000877	0.00112	CcSEcCtD
Zanamivir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000872	0.00111	CcSEcCtD
Zanamivir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000871	0.00111	CcSEcCtD
Zanamivir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00087	0.00111	CcSEcCtD
Zanamivir—Discomfort—Losartan—type 2 diabetes mellitus	0.000869	0.00111	CcSEcCtD
Zanamivir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000866	0.00111	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000865	0.0011	CcSEcCtD
Zanamivir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000865	0.0011	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000862	0.00398	CbGpPWpGaD
Zanamivir—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000854	0.00109	CcSEcCtD
Zanamivir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000853	0.00109	CcSEcCtD
Zanamivir—Confusional state—Losartan—type 2 diabetes mellitus	0.00085	0.00109	CcSEcCtD
Zanamivir—NEU2—Metabolism—GCKR—type 2 diabetes mellitus	0.000849	0.00393	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000849	0.00393	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LPA—type 2 diabetes mellitus	0.000849	0.00393	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000849	0.00393	CbGpPWpGaD
Zanamivir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000849	0.00108	CcSEcCtD
Zanamivir—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000847	0.00108	CcSEcCtD
Zanamivir—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000843	0.00108	CcSEcCtD
Zanamivir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000843	0.00108	CcSEcCtD
Zanamivir—Infection—Losartan—type 2 diabetes mellitus	0.000838	0.00107	CcSEcCtD
Zanamivir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000836	0.00107	CcSEcCtD
Zanamivir—Shock—Losartan—type 2 diabetes mellitus	0.00083	0.00106	CcSEcCtD
Zanamivir—Urticaria—Valsartan—type 2 diabetes mellitus	0.000828	0.00106	CcSEcCtD
Zanamivir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000826	0.00105	CcSEcCtD
Zanamivir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000824	0.00105	CcSEcCtD
Zanamivir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000822	0.00105	CcSEcCtD
Zanamivir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000821	0.00105	CcSEcCtD
Zanamivir—Fatigue—Metformin—type 2 diabetes mellitus	0.000819	0.00104	CcSEcCtD
Zanamivir—Urticaria—Orlistat—type 2 diabetes mellitus	0.000819	0.00104	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000817	0.00377	CbGpPWpGaD
Zanamivir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000816	0.00104	CcSEcCtD
Zanamivir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000815	0.00104	CcSEcCtD
Zanamivir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000815	0.00104	CcSEcCtD
Zanamivir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000814	0.00104	CcSEcCtD
Zanamivir—Agitation—Ramipril—type 2 diabetes mellitus	0.000814	0.00104	CcSEcCtD
Zanamivir—NEU2—Metabolism—ALDOB—type 2 diabetes mellitus	0.000814	0.00376	CbGpPWpGaD
Zanamivir—Anorexia—Losartan—type 2 diabetes mellitus	0.000804	0.00103	CcSEcCtD
Zanamivir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000804	0.00103	CcSEcCtD
Zanamivir—Malaise—Ramipril—type 2 diabetes mellitus	0.000799	0.00102	CcSEcCtD
Zanamivir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000799	0.00102	CcSEcCtD
Zanamivir—Rash—Glyburide—type 2 diabetes mellitus	0.000797	0.00102	CcSEcCtD
Zanamivir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000796	0.00102	CcSEcCtD
Zanamivir—Syncope—Ramipril—type 2 diabetes mellitus	0.000795	0.00101	CcSEcCtD
Zanamivir—Headache—Glyburide—type 2 diabetes mellitus	0.000792	0.00101	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000791	0.00366	CbGpPWpGaD
Zanamivir—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000783	0.000999	CcSEcCtD
Zanamivir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000779	0.000994	CcSEcCtD
Zanamivir—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000779	0.000994	CcSEcCtD
Zanamivir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000777	0.000991	CcSEcCtD
Zanamivir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000777	0.000991	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000775	0.00358	CbGpPWpGaD
Zanamivir—Cough—Ramipril—type 2 diabetes mellitus	0.000773	0.000987	CcSEcCtD
Zanamivir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000773	0.000986	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000768	0.000981	CcSEcCtD
Zanamivir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000768	0.00098	CcSEcCtD
Zanamivir—Convulsion—Ramipril—type 2 diabetes mellitus	0.000768	0.00098	CcSEcCtD
Zanamivir—Pain—Irbesartan—type 2 diabetes mellitus	0.000766	0.000978	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000766	0.00354	CbGpPWpGaD
Zanamivir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000759	0.000969	CcSEcCtD
Zanamivir—NEU2—Metabolism—GLP1R—type 2 diabetes mellitus	0.000757	0.0035	CbGpPWpGaD
Zanamivir—Urticaria—Metformin—type 2 diabetes mellitus	0.000754	0.000963	CcSEcCtD
Zanamivir—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000754	0.000963	CcSEcCtD
Zanamivir—Myalgia—Ramipril—type 2 diabetes mellitus	0.000754	0.000963	CcSEcCtD
Zanamivir—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000752	0.000959	CcSEcCtD
Zanamivir—Anxiety—Ramipril—type 2 diabetes mellitus	0.000752	0.000959	CcSEcCtD
Zanamivir—Nausea—Glyburide—type 2 diabetes mellitus	0.000751	0.000958	CcSEcCtD
Zanamivir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000751	0.000958	CcSEcCtD
Zanamivir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000751	0.000958	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000749	0.000956	CcSEcCtD
Zanamivir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000748	0.000955	CcSEcCtD
Zanamivir—Discomfort—Ramipril—type 2 diabetes mellitus	0.000745	0.000951	CcSEcCtD
Zanamivir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000739	0.000943	CcSEcCtD
Zanamivir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000738	0.000942	CcSEcCtD
Zanamivir—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000733	0.000936	CcSEcCtD
Zanamivir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000733	0.000935	CcSEcCtD
Zanamivir—Confusional state—Ramipril—type 2 diabetes mellitus	0.000729	0.00093	CcSEcCtD
Zanamivir—Fatigue—Losartan—type 2 diabetes mellitus	0.000727	0.000928	CcSEcCtD
Zanamivir—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000723	0.000923	CcSEcCtD
Zanamivir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000722	0.000921	CcSEcCtD
Zanamivir—Pain—Losartan—type 2 diabetes mellitus	0.000721	0.00092	CcSEcCtD
Zanamivir—Rash—Gliclazide—type 2 diabetes mellitus	0.000716	0.000913	CcSEcCtD
Zanamivir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000715	0.000912	CcSEcCtD
Zanamivir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000713	0.00091	CcSEcCtD
Zanamivir—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000712	0.000908	CcSEcCtD
Zanamivir—Shock—Ramipril—type 2 diabetes mellitus	0.000711	0.000908	CcSEcCtD
Zanamivir—Headache—Gliclazide—type 2 diabetes mellitus	0.000711	0.000907	CcSEcCtD
Zanamivir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000708	0.000904	CcSEcCtD
Zanamivir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000708	0.000904	CcSEcCtD
Zanamivir—NEU2—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000707	0.00327	CbGpPWpGaD
Zanamivir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000705	0.0009	CcSEcCtD
Zanamivir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000702	0.000896	CcSEcCtD
Zanamivir—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000695	0.000887	CcSEcCtD
Zanamivir—NEU2—Metabolism—MTR—type 2 diabetes mellitus	0.000692	0.0032	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CPT1A—type 2 diabetes mellitus	0.000692	0.0032	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000692	0.0032	CbGpPWpGaD
Zanamivir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00069	0.00088	CcSEcCtD
Zanamivir—Dizziness—Valsartan—type 2 diabetes mellitus	0.00069	0.00088	CcSEcCtD
Zanamivir—Anorexia—Ramipril—type 2 diabetes mellitus	0.000689	0.00088	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000683	0.00316	CbGpPWpGaD
Zanamivir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000681	0.00087	CcSEcCtD
Zanamivir—Asthenia—Metformin—type 2 diabetes mellitus	0.000681	0.000869	CcSEcCtD
Zanamivir—NEU2—Metabolism—NAMPT—type 2 diabetes mellitus	0.000679	0.00314	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000675	0.00312	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LIPC—type 2 diabetes mellitus	0.000675	0.00312	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HBA1—type 2 diabetes mellitus	0.000675	0.00312	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GCK—type 2 diabetes mellitus	0.000675	0.00312	CbGpPWpGaD
Zanamivir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000674	0.00086	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP11A1—type 2 diabetes mellitus	0.00067	0.0031	CbGpPWpGaD
Zanamivir—Urticaria—Losartan—type 2 diabetes mellitus	0.00067	0.000855	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.00067	0.00309	CbGpPWpGaD
Zanamivir—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000667	0.000851	CcSEcCtD
Zanamivir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000667	0.000851	CcSEcCtD
Zanamivir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000663	0.000846	CcSEcCtD
Zanamivir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00066	0.000843	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000659	0.000841	CcSEcCtD
Zanamivir—NEU2—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000658	0.00304	CbGpPWpGaD
Zanamivir—Rash—Valsartan—type 2 diabetes mellitus	0.000658	0.000839	CcSEcCtD
Zanamivir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000657	0.000838	CcSEcCtD
Zanamivir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000655	0.000836	CcSEcCtD
Zanamivir—Headache—Valsartan—type 2 diabetes mellitus	0.000653	0.000834	CcSEcCtD
Zanamivir—NEU2—Metabolism—CETP—type 2 diabetes mellitus	0.000651	0.00301	CbGpPWpGaD
Zanamivir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00065	0.000829	CcSEcCtD
Zanamivir—Rash—Orlistat—type 2 diabetes mellitus	0.00065	0.000829	CcSEcCtD
Zanamivir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000649	0.000828	CcSEcCtD
Zanamivir—Headache—Orlistat—type 2 diabetes mellitus	0.000646	0.000824	CcSEcCtD
Zanamivir—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000645	0.000823	CcSEcCtD
Zanamivir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000643	0.00082	CcSEcCtD
Zanamivir—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000629	0.000802	CcSEcCtD
Zanamivir—Dizziness—Metformin—type 2 diabetes mellitus	0.000628	0.000801	CcSEcCtD
Zanamivir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000623	0.000796	CcSEcCtD
Zanamivir—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000621	0.000793	CcSEcCtD
Zanamivir—Nausea—Valsartan—type 2 diabetes mellitus	0.000619	0.00079	CcSEcCtD
Zanamivir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000613	0.000782	CcSEcCtD
Zanamivir—Nausea—Orlistat—type 2 diabetes mellitus	0.000612	0.000781	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000607	0.00281	CbGpPWpGaD
Zanamivir—Asthenia—Losartan—type 2 diabetes mellitus	0.000605	0.000772	CcSEcCtD
Zanamivir—NEU2—Metabolism—SREBF1—type 2 diabetes mellitus	0.000605	0.0028	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SNAP25—type 2 diabetes mellitus	0.000605	0.0028	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PSMD6—type 2 diabetes mellitus	0.000605	0.0028	CbGpPWpGaD
Zanamivir—Vomiting—Metformin—type 2 diabetes mellitus	0.000604	0.00077	CcSEcCtD
Zanamivir—Rash—Metformin—type 2 diabetes mellitus	0.000599	0.000764	CcSEcCtD
Zanamivir—Dermatitis—Metformin—type 2 diabetes mellitus	0.000598	0.000763	CcSEcCtD
Zanamivir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000596	0.00076	CcSEcCtD
Zanamivir—Headache—Metformin—type 2 diabetes mellitus	0.000595	0.000759	CcSEcCtD
Zanamivir—NEU2—Metabolism—CTGF—type 2 diabetes mellitus	0.000594	0.00275	CbGpPWpGaD
Zanamivir—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000593	0.000756	CcSEcCtD
Zanamivir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000591	0.000755	CcSEcCtD
Zanamivir—NEU2—Metabolism—HMGCR—type 2 diabetes mellitus	0.000589	0.00272	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000581	0.00268	CbGpPWpGaD
Zanamivir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000577	0.000736	CcSEcCtD
Zanamivir—NEU2—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000576	0.00266	CbGpPWpGaD
Zanamivir—Urticaria—Ramipril—type 2 diabetes mellitus	0.000574	0.000733	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—INS—type 2 diabetes mellitus	0.000572	0.00264	CbGpPWpGaD
Zanamivir—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000572	0.000729	CcSEcCtD
Zanamivir—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000572	0.000729	CcSEcCtD
Zanamivir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00057	0.000727	CcSEcCtD
Zanamivir—Rash—Irbesartan—type 2 diabetes mellitus	0.000565	0.000721	CcSEcCtD
Zanamivir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000565	0.00072	CcSEcCtD
Zanamivir—Nausea—Metformin—type 2 diabetes mellitus	0.000564	0.00072	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—CCL2—type 2 diabetes mellitus	0.000563	0.0026	CbGpPWpGaD
Zanamivir—Headache—Irbesartan—type 2 diabetes mellitus	0.000561	0.000716	CcSEcCtD
Zanamivir—Dizziness—Losartan—type 2 diabetes mellitus	0.000558	0.000712	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000553	0.00256	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—IGF1—type 2 diabetes mellitus	0.000553	0.00256	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000547	0.00253	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000547	0.00253	CbGpPWpGaD
Zanamivir—Vomiting—Losartan—type 2 diabetes mellitus	0.000536	0.000684	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000534	0.00247	CbGpPWpGaD
Zanamivir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000533	0.00068	CcSEcCtD
Zanamivir—Nausea—Irbesartan—type 2 diabetes mellitus	0.000532	0.000679	CcSEcCtD
Zanamivir—Rash—Losartan—type 2 diabetes mellitus	0.000532	0.000679	CcSEcCtD
Zanamivir—Dermatitis—Losartan—type 2 diabetes mellitus	0.000531	0.000678	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000531	0.00245	CbGpPWpGaD
Zanamivir—Headache—Losartan—type 2 diabetes mellitus	0.000528	0.000674	CcSEcCtD
Zanamivir—NEU2—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000525	0.00243	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GCG—type 2 diabetes mellitus	0.000525	0.00243	CbGpPWpGaD
Zanamivir—Asthenia—Ramipril—type 2 diabetes mellitus	0.000519	0.000662	CcSEcCtD
Zanamivir—Nausea—Losartan—type 2 diabetes mellitus	0.000501	0.000639	CcSEcCtD
Zanamivir—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000495	0.000631	CcSEcCtD
Zanamivir—Dizziness—Ramipril—type 2 diabetes mellitus	0.000478	0.00061	CcSEcCtD
Zanamivir—Vomiting—Ramipril—type 2 diabetes mellitus	0.00046	0.000587	CcSEcCtD
Zanamivir—Rash—Ramipril—type 2 diabetes mellitus	0.000456	0.000582	CcSEcCtD
Zanamivir—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000456	0.000581	CcSEcCtD
Zanamivir—Headache—Ramipril—type 2 diabetes mellitus	0.000453	0.000578	CcSEcCtD
Zanamivir—NEU2—Metabolism—GNB3—type 2 diabetes mellitus	0.000452	0.00209	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000452	0.00209	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HMOX1—type 2 diabetes mellitus	0.00045	0.00208	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CAT—type 2 diabetes mellitus	0.000444	0.00205	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOB—type 2 diabetes mellitus	0.000431	0.00199	CbGpPWpGaD
Zanamivir—Nausea—Ramipril—type 2 diabetes mellitus	0.00043	0.000548	CcSEcCtD
Zanamivir—NEU2—Metabolism—GSTM1—type 2 diabetes mellitus	0.000419	0.00194	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LPL—type 2 diabetes mellitus	0.000412	0.0019	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ADCY5—type 2 diabetes mellitus	0.000403	0.00186	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GPX1—type 2 diabetes mellitus	0.000402	0.00186	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CD36—type 2 diabetes mellitus	0.000391	0.00181	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000386	0.00179	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—MTHFR—type 2 diabetes mellitus	0.000371	0.00171	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPARA—type 2 diabetes mellitus	0.000364	0.00168	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AGT—type 2 diabetes mellitus	0.000352	0.00163	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CALM1—type 2 diabetes mellitus	0.000346	0.0016	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOE—type 2 diabetes mellitus	0.000345	0.0016	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOA1—type 2 diabetes mellitus	0.000341	0.00158	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPARG—type 2 diabetes mellitus	0.000301	0.00139	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—INS—type 2 diabetes mellitus	0.000295	0.00136	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALB—type 2 diabetes mellitus	0.00027	0.00125	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000259	0.00119	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NOS3—type 2 diabetes mellitus	0.000259	0.00119	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGS2—type 2 diabetes mellitus	0.000236	0.00109	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AKT1—type 2 diabetes mellitus	0.000119	0.000549	CbGpPWpGaD
